Basilea Pharmaceutica International Ltd. / The Wellcome Trust / Basilea Basilea Pharmaceutica Ltd. / Basilea Pharmaceutica Ltd. / cancer/ About Wellcome Trust / Russell Group / Cancer Research UK / 3 Basilea Pharmaceutica Ltd. / /
Country
Switzerland / United Kingdom / /
Currency
GBP / / /
Facility
University of Manchester / About The Institute of Cancer Research / London The Institute of Cancer Research / About The University of Manchester The University of Manchester / The Institute of Cancer Research / University of London / The University of Manchester / /
IndustryTerm
cancer therapy / cancer therapies / cancer therapeutics / cancer treatment / treatment of cancer / biopharmaceutical company developing products / pharmaceutical products / /
MedicalCondition
BRAF mutant melanoma / resistant tumor / melanoma / fungal infections / cancers / influential cancer / tumor / cancer / genetic disease / bacterial infections / tumors / additional cancer / top four cancer / malaria / international cancer / drug-resistant cancers / targeted cancer / personalized cancer / /
MedicalTreatment
cancer therapy / cancer therapies / cancer therapeutics / /
Organization
University of Manchester / NHS / Institute of Cancer Research / University of London / /
Person
Caroline Springer / Laurenz Kellenberger / Nils Schröder / Barbara Zink / / /
Position
MBA Head Public Relations & Head Corporate Development Corporate Communications / specialist research groups / Chief Scientific Officer / Professor / Professor of Biological Chemistry / /
Microsoft Word - 20150401_Basilea_In-licensing panRAF_EN.docx